Vertex announces retirement of Peter Mueller
This article was originally published in Scrip
Executive Summary
Vertex Pharmaceuticals has announced that Dr Peter Mueller, its executive vice-president of global research and development and chief scientific officer, will retire after more than 10 years with the company. Dr Mueller's retirement will be effective 31 October 2014, following a planned transition period, Vertex said. He joined the Boston, Massachusetts-based company in 2003 as chief scientific officer and senior vice-president, drug discovery and innovation. Vertex expects to appoint a new head of global research to oversee the company's drug discovery efforts following Dr Mueller's retirement later this year.